MR [Mindray Medical International] UPLOAD: (Original Filing)
[]
DQ [DAQO NEW ENERGY] 6-K: (Original Filing)
[Daqo New Energy Announces Second Quarter 2012 Results CHONGQING, ChinaAugust 17, 2012Daqo New Energy Corp. (NYSE: DQ) (Daqo New Energy or the Company), a leading polysilicon manufacturer based in China, today announced its unaudited financial results for the second quarter of 2012. Second Quarter 2012 Financial and Operating Highlights Polysilicon shipments were approximately 1028 metric tons, or MT. Photovoltaic]
DQ [DAQO NEW ENERGY] 6-K: Daqo New Energy Announces Second Quarter 2012 Results
[Daqo New Energy Announces Second Quarter 2012 Results CHONGQING, ChinaAugust 17, 2012Daqo New Energy Corp. (NYSE: DQ) (Daqo New Energy or the Company), a leading polysilicon manufacturer based in China, today announced its unaudited financial results for the second quarter of 2012. Second Quarter 2012 Financial and Operating Highlights Polysilicon shipments were approximately 1028 metric tons, or MT. Photovoltaic]
BSPM [Biostar Pharmaceuticals,] S-8: (Original Filing)
[FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Biostar Pharmaceuticals, Inc. Maryland (State or other jurisdiction of incorporation or organization) 20-5101287 (I.R.S. Employer Identification No.) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 including zip code) (Full title of the plan) Ronghua Wang President and Chief Executive Officer No. 588 Shiji Xi Avenue] [Biostar Pharmaceuticals, Inc. 2011 Stock Option Compensation Plan This Biostar Pharmaceuticals, Inc. 2011 Stock Option Compensation Plan Plan 1. Definitions. (a) Board " (b) Code " (c) Committee Rule 16b-3 Exchange Act " (d) Company " (e) Exchange Act " (f) Fair Market Value " (g) Grant " (h) Grant Agreement " (i) Maryland Securities Rules " (j) Option Optionee] [[Cozen O’Connor Letterhead] August 16, 2012 Biostar Pharmaceuticals, Inc. No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 Re: Registration Statement on Form S-8 Very truly yours, EX-5 3 ex5-1.htm] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Inc. We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 of Biostar Pharmaceuticals, Inc. of our report dated March 27, 2012 relating to the consolidation financial statements, which appears in the Annual Report on Form 10-K of Biostar Pharmaceuticals,]
BSPM [Biostar Pharmaceuticals,] S-8: FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT
[FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Biostar Pharmaceuticals, Inc. Maryland (State or other jurisdiction of incorporation or organization) 20-5101287 (I.R.S. Employer Identification No.) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 including zip code) (Full title of the plan) Ronghua Wang President and Chief Executive Officer No. 588 Shiji Xi Avenue] [Biostar Pharmaceuticals, Inc. 2011 Stock Option Compensation Plan This Biostar Pharmaceuticals, Inc. 2011 Stock Option Compensation Plan Plan 1. Definitions. (a) Board " (b) Code " (c) Committee Rule 16b-3 Exchange Act " (d) Company " (e) Exchange Act " (f) Fair Market Value " (g) Grant " (h) Grant Agreement " (i) Maryland Securities Rules " (j) Option Optionee] [[Cozen O’Connor Letterhead] August 16, 2012 Biostar Pharmaceuticals, Inc. No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 Re: Registration Statement on Form S-8 Very truly yours, EX-5 3 ex5-1.htm] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Inc. We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 of Biostar Pharmaceuticals, Inc. of our report dated March 27, 2012 relating to the consolidation financial statements, which appears in the Annual Report on Form 10-K of Biostar Pharmaceuticals,]
DQ [DAQO NEW ENERGYRP.] 6-K: Daqo New Energy Announces Second Quarter 2012 Results
[Daqo New Energy Announces Second Quarter 2012 Results STYLE="font-family:Times New Roman" SIZE="2"> CHONGQING, ChinaAugust 17, 2012Daqo New Energyrp. (NYSE: DQ) (Daqo New Energy or thempany), a leading polysilicon manufacturer based in China, today announced its unaudited financial results for the second quarter of 2012. Second Quarter 2012 Financial and Operating Highlights]
HPJ [Highpower International] 10-Q: (Original Filing)
[] [I, Dang Yu Pan, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Highpower International, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [I, Henry Sun, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Highpower International, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dang Yu Pan Chairman of the Board and Chief Executive Officer August 16, 2012 Henry Sun Chief Financial Officer (Principal Financial and Accounting Officer) August 16, 2012] [Comprehensive credit contract Fiduciary: SHENZHEN HIGHPOWER TECHNOLOGY CO., LTD. (hereinafter referred to Party A) Credit: Zhuhai China Resources Bank Co., Ltd., SHENZHEN BRANCH (sub, sub-branches) (hereinafter referred to Party B) Applying by Party A, Party B agrees to provide the Party A the line of credit. In accordance with the provisions of relevant laws, after full consultation, Party A and] [Loans Operations Centre Tel: (852) 3518 5888 Fax: (852) 2868 0726 Email: loansopctr@winglungbank.com www.winglungbank.com IMPORTANT NOTICE: THIS LETTER SETS OUT THE TERMS AND CONDITIONS UPON WHICH OUR BANK WOULD PROVIDE BANKING FACILITIES TO YOU. YOU ARE ADVISED TO READ AND UNDERSTAND SUCH TERMS AND CONDITIONS BEFORE ACCEPTING THIS LETTER, OR IF YOU CONSIDER NECESSARY, SEEK INDEPENDENT LEGAL ADVICE. Our Ref:]
